Bank of Montreal
MCRB icon

Bank of Montreal’s Seres Therapeutics MCRB Stock Holding History

Bank of Montreal’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15
Closed -$3K – 4105
2016
Q4 		$3K Hold
15
– – ﹤0.01% 3832
2016
Q3 		$4K Buy
+15
New +$5.26K ﹤0.01% 3762

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bank of Montreal's MCRB Position: Q2 2021 in Review

Bank of Montreal sold out of Seres Therapeutics (MCRB) in Q2 2021, closing a stake of 125 shares — an estimated $51K sold.

Bank of Montreal first reported a position in MCRB in Q3 2016 and held it in 18 quarters. The position peaked at $1.51M in Q3 2020. 146 funds tracked by Wall St. Rank hold MCRB as of Q2 2021.

  • Bank of Montreal reported no remaining Seres Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 125 Seres Therapeutics shares in Q2 2021, an estimated $51K.
  • Bank of Montreal first reported a position in Seres Therapeutics in Q3 2016 and held it in 18 quarters.
  • Bank of Montreal's Seres Therapeutics position peaked at $1.51M in Q3 2020.
  • 146 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.